P
Plus Therapeutics, Inc. (PSTV)
NCM – Real Time Price. Currency in USD
4.20
-0.06 (-1.41%)
At close: Jun 26, 2026, 4:00 PM EDT
4.16
-0.04 (-0.95%)
After-hours: Jun 26, 2026, 7:41 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
4.20
-0.06 (-1.41%)
At close: Jun 26, 2026, 4:00 PM EDT
4.16
-0.04 (-0.95%)
After-hours: Jun 26, 2026, 7:41 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $3.0M significantly exceed its total debt $725.0K, ensuring strong financial flexibility
Total current assets $17.6M exceed Total current liabilities $8.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-418.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$7.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.21 | 6.05 | 10 | |
| Quick ratio | 2.21 | 5.63 | 10 | |
| Debt to Equity | 0.06 | 0.30 | 9.0 | |
| Debt to Assets | 0.04 | 1.04 | 9.0 | |
| Interest coverage | -418.76 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 224K | 5M | 6M | 5M | 5M |
| Gross Profit | -488K | 4M | 5M | 5M | 5M |
| Operating Income | -20M | -13M | -15M | -15M | -19M |
| Net Income | -20M | -13M | -13M | -22M | -16M |
| EBITDA | -19M | -13M | -14M | -15M | -19M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -19.9 | -276 | 1.0 |
| Next quarter | 1.67 | 14 | 5.5 |
| Current year | 19.76 | 45.1 | 9.5 |
| Next year | 223.03 | 40.7 | 10 |
| Weighted average score | 6.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -24.79 | -21.57 | -25.95 | -12.22 | 1.0 |
| Y/Y | -2.92 | 60.08 | 96.47 | -14.26 | 5.5 |
| 3y average | 700.45 | -11.86 | 67.48 | -24.5 | 5.5 |
| 5y average | 600.07 | -29.89 | 54.68 | -25.01 | 5.5 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |